Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/10854/2816

Clopidogrel Pharmacogenetics, resistance to antiplatelet therapy in ischemic stroke by Epigenome Wide Association Study (EWAS).
Gallego Fàbrega, Cristina
Universitat de Vic. Escola Politècnica Superior; Universitat de Vic. Màster Universitari en Anàlisi de Dades Òmiques
Clopidogrel is a widely used antiplatelet drug used in preventing vascular events after suffering a first stoke. Genome-wide association studies (GWAS) has not been able to establish a clear association between polymorphisms and recurrence. Therefore in the present final master project an epigenetic approach is proposed. Using an array based technology, 450.000 CpG sites across all genome were assessed in 48 individuals (21 cases and 21 controls). Looking at differentially methylated levels between cases and controls, 58 CpG sites (DMGs) were found. Although, no clear locus was observed. Looking individually to each 49 genes, two appeared to be important to our study. TRAF3 and ADAMTS2 are gens highly related to platelet aggregation. In orther to confirm these result, a new DNA methylation study will be done in a larger cohort, using Sequenom technology.
Curs 2012-2013
03-2014
Epigenètica
ADN
Malalties cerebrovasculars
Aquest document està subjecte a una llicència Creative Commons:
25 p.
info:eu-repo/semantics/masterThesis
         

Documentos con el texto completo de este documento

Ficheros Tamaño Formato
trealu_a2013_gallego_cristina_clopidogrel.pdf 292.7 KB PDF

Mostrar el registro completo del ítem